HistoSonics has closed its latest financing with additional investment from friends of the Foundation, facilitated by the new FUS Partners program. The round, led by Foundation board member and serial entrepreneur Fred Moll (Auris Surgical Robotics, Intuitive Surgical, Hansen Medical), solidly positions HistoSonics for future growth. CEO Mike Blue expressed his appreciation to the Foundation and his new investors, saying, “We are grateful for the additional support and are excited about the future.”
Filling out the HistoSonics round shows the Partners program in action as designed: staying in regular touch with Mike Blue kept the Foundation current on how the financing was coming together and that there might be an opportunity for a few additional investors. Our targeted emails resulted in expressions of interest, which we promptly conveyed to the company, and they became commitments to join the round.
In this way, the Partners program helps the Foundation accelerate the pace of focused ultrasound adoption at a critical time. By staying in touch with focused ultrasound companies, we better understand their strategies and progress, including potential financing and partnering needs. We do the same with investors of all types and around the world. There are no fees for investor introductions or partnership facilitation, though the Foundation is of course happy to accept donations from program participants grateful for its assistance. As each company grows stronger, so does the entire focused ultrasound ecosystem.